MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5489/cuaj.9312

Медицинская библиотека · Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025

Comparative analysis of apixaban vs. enoxaparin for thromboprophylaxis after radical cystectomy A single-center, observational, before-after study.

Macklin Cory S, Reznik Gabrielle, Gleave Martin E, Mannas Miles P, Black Peter C, St-Laurent Marie-Pier

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Radical cystectomy (RC) is the standard treatment for muscle-invasive and select high-risk non-muscle-invasive bladder cancer. Venous thromboembolism (VTE) is a common and preventable postoperative complication. Extended thromboprophylaxis with low-molecular-weight heparin, such as enoxaparin, is recommended, but direct-acting oral anticoagulants like apixaban are a possible alternative. This study evaluated the safety and efficacy of apixaban compared to enoxaparin for extended postoperative thromboprophylaxis following RC.

METHODS

A single-center, observational, before-after study of RCs performed between October 2021 and August 2024 was conducted. Patients receiving 28 days of post-discharge thromboprophylaxis with either enoxaparin or apixaban were included. The primary outcome was postoperative VTE within 30 days. Secondary outcomes included 90-day postoperative VTE, 30-day post-discharge emergency room (ER) visits, readmissions, complications such as bleeding, and 90-day postoperative mortality.

RESULTS

A total of 102 patients who received enoxaparin and 83 patients who received apixaban for VTE thromboprophylaxis were included. No significant differences were found in 30-day postoperative VTE rates (0 [0%] apixaban vs. 2 [2%] enoxaparin, p=0.5), 90-day VTE rates, 90-day overall survival, or 30-day post-discharge ER visits, readmissions, or hemorrhagic complications (p>0.05).

CONCLUSIONS

Apixaban appears to be a safe and effective alternative to enoxaparin for extended postoperative VTE prophylaxis following RC for bladder cancer.

Для цитирования: Macklin Cory S, Reznik Gabrielle, Gleave Martin E, Mannas Miles P, Black Peter C, St-Laurent Marie-Pier. Comparative analysis of apixaban vs. enoxaparin for thromboprophylaxis after radical cystectomy A single-center, observational, before-after study.. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2025. DOI: 10.5489/cuaj.9312.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.